Clinical Trial Update: Ifosfamide/Carboplatin/Etoposide/Rituxan Followed by Zevalin in Relapsed/Refractory Intermediate Grade B-Cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing a chemotherapy regimen (Ifosfamide, Carboplatin, Etoposide) with Rituximab followed by Zevalin for relapsed/refractory intermediate-gr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)
• IFOSFAMIDE (IFOSFAMIDE)
• Rituxan (rituximab)
• Zevalin (ibritumomab tiuxetan)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Non-Hodgkins Lymphoma | Phase 2 | Status: COMPLETED